MedTrace Logo

Outcome of Patients Treated With ECLS

NCT04405817 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-05-28

No results posted yet for this study

Summary

Extracorporeal life support (ECLS), also called extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique of providing effective circulatory and (or) respiratory failure, with a growing number of critically ill patients benefit from it. The aim of this study is to investigate the outcome of patients treated With ECMO, and to evaluate the short-term and long-term outcomes of patients with ECLS.

Conditions

  • Cardiogenic Shock
  • Cardiac Arrest
  • Heart Failure
  • Acute Respiratory Failure
  • Acute Respiratory Distress Syndrome

Interventions

DEVICE

ECMO

ECMO for circulatory and/or respiratory support

Sponsors & Collaborators

  • Nanjing Medical University

    lead OTHER

Principal Investigators

  • Yong-feng Shao · The First Affiliated Hospital with Nanjing Medical University

Eligibility

Min Age
1 Year
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04405817 on ClinicalTrials.gov